Skip to main content
SpringerLink
Log in

Mental Health in Chronic and End-Stage Lung Disease

  • Chapter
  • First Online:
Psychosocial Care of End-Stage Organ Disease and Transplant Patients

Abstract

As with many other chronic illnesses, patients with pulmonary disorders have increased rates of psychiatric conditions, in particular anxiety and depression. As pulmonary diseases progress, they profoundly affect patient’s physical, vocational, and emotional functioning. In addition, psychological conditions further decrease quality of life and make management of pulmonary conditions more challenging. In this chapter, we discuss the psychiatric conditions accompanying lung disorders leading to lung transplantation, including epidemiology, risk factors, significance, and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Courtwright AM, Salomon S, Lehmann LS, Wolfe DJ, Goldberg HJ. The Effect of Pretransplant Depression and Anxiety on Survival Following Lung Transplant: A Meta-analysis. Psychosomatics. [Meta-Analysis Review]. 2016;57(3):238–45.

    Article  Google Scholar 

  2. Courtwright AM, Salomon S, Lehmann LS, Brettler T, Divo M, Camp P, et al. The association between mood, anxiety and adjustment disorders and hospitalization following lung transplantation. Gen Hosp Psychiatry. [Research Support, N.I.H., Extramural]. 2016;41:1–5.

    Article  Google Scholar 

  3. Hitschfeld MJ, Schneekloth TD, Kennedy CC, Rummans TA, Niazi SK, Vasquez AR, et al. The psychosocial assessment of candidates for transplantation: a cohort study of its association with survival among lung transplant recipients. Psychosomatics. 2016;57(5):489–97.

    Article  Google Scholar 

  4. Smith PJ, Blumenthal JA, Carney RM, Freedland KE, O’Hayer CV, Trulock EP, et al. Neurobehavioral functioning and survival following lung transplantation. Chest. [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, P.H.S.]. 2014;145(3):604–11.

    Google Scholar 

  5. Committee TGS. Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2016.

    Google Scholar 

  6. Schauer GL, Wheaton AG, Malarcher AM, Croft JB. Smoking prevalence and cessation characteristics among U.S. adults with and without COPD: findings from the 2011 behavioral risk factor surveillance system. COPD. 2014;11(6):697–704.

    Article  Google Scholar 

  7. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. [Research Support, Non-U.S. Gov’t]. 2006;61(11):935–9.

    Article  CAS  Google Scholar 

  8. Flensborg-Madsen T, von Scholten MB, Flachs EM, Mortensen EL, Prescott E, Tolstrup JS. Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study. J Psychiatr Res. [Research Support, Non-U.S. Gov’t]. 2011;45(2):143–9.

    Article  Google Scholar 

  9. Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. [Review]. 2013;58(5):858–66.

    Google Scholar 

  10. Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med. [Comparative Study Controlled Clinical Trial Research Support, N.I.H., Extramural Validation Studies]. 2006;21(11):1133–7.

    Article  Google Scholar 

  11. Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis. [Review]. 2014;6(11):1615–31.

    Google Scholar 

  12. Matte DL, Pizzichini MM, Hoepers AT, Diaz AP, Karloh M, Dias M, et al. Prevalence of depression in COPD: a systematic review and meta-analysis of controlled studies. Respir Med. [Review]. 2016;117:154–61.

    Article  Google Scholar 

  13. Hanania NA, Mullerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2011;183(5):604–11.

    Google Scholar 

  14. Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, et al. Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat. [Review]. 2016;12:297–328.

    Google Scholar 

  15. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. [Meta-Analysis Review]. 2013;144(3):766–77.

    Article  Google Scholar 

  16. Stage KB, Middelboe T, Pisinger C. Depression and chronic obstructive pulmonary disease (COPD). Impact on survival. Acta Psychiatr Scand. 2005;111(4):320–3.

    Article  CAS  Google Scholar 

  17. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2007;167(1):60–7.

    Google Scholar 

  18. Qian J, Simoni-Wastila L, Langenberg P, Rattinger GB, Zuckerman IH, Lehmann S, et al. Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease. J Am Geriatr Soc. [Comparative Study Research Support, N.I.H., Extramural]. 2013;61(5):754–61.

    Article  Google Scholar 

  19. Moylan S, Jacka FN, Pasco JA, Berk M. Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. BMC Med. [Research Support, Non-U.S. Gov’t Review]. 2012;10:123.

    Google Scholar 

  20. Hsu JH, Chien IC, Lin CH, Chou YJ, Chou P. Increased risk of chronic obstructive pulmonary disease in patients with schizophrenia: a population-based study. Psychosomatics. 2013;54(4):345–51.

    Article  Google Scholar 

  21. Hsu JH, Chien IC, Lin CH. Increased risk of chronic obstructive pulmonary disease in patients with bipolar disorder: a population-based study. J Affect Disord. 2017;220:43–8.

    Article  Google Scholar 

  22. Kakkera K, Padala KP, Kodali M, Padala PR. Association of chronic obstructive pulmonary disease with mild cognitive impairment and dementia. Curr Opin Pulm Med. 2018;24(2):173–8.

    PubMed  Google Scholar 

  23. Ouellette DR, Lavoie KL. Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD. Int J Chron Obstruct Pulmon Dis. [Review]. 2017;12:639–50.

    Article  Google Scholar 

  24. Schou L, Ostergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K. Cognitive dysfunction in patients with chronic obstructive pulmonary disease – a systematic review. Respir Med. [Research Support, Non-U.S. Gov’t Review]. 2012;106(8):1071–81.

    Article  Google Scholar 

  25. Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. [Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. 2014;71(5):581–8.

    Google Scholar 

  26. Hayes TL, Larimer N, Adami A, Kaye JA. Medication adherence in healthy elders: small cognitive changes make a big difference. J Aging Health. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]. 2009;21(4):567–80.

    Article  Google Scholar 

  27. Vinyoles E, De la Figuera M, Gonzalez-Segura D. Cognitive function and blood pressure control in hypertensive patients over 60 years of age: COGNIPRES study. Curr Med Res Opin. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2008;24(12):3331–9.

    Google Scholar 

  28. Kotz D, Viechtbauer W, Simpson CR, van Schayck OCP, West R, Sheikh A. Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease. Thorax. [Research Support, Non-U.S. Gov’t]. 2017;72(10):905–11.

    Google Scholar 

  29. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. [Clinical Trial Randomized Controlled Trial Research Support, U.S. Gov’t, Non-P.H.S.]. 1992 Spring;33(2):190–201.

    Article  CAS  Google Scholar 

  30. Light RW, Merrill EJ, Despars J, Gordon GH, Mutalipassi LR. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med. [Clinical Trial Controlled Clinical Trial]. 1986;146(7):1377–80.

    Article  CAS  Google Scholar 

  31. Gordon GH, Michiels TM, Mahutte CK, Light RW. Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease. Psychiatry Res. [Clinical Trial]. 1985;15(1):25–32.

    Article  CAS  Google Scholar 

  32. Lacasse Y, Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 2004;61(3):140–7.

    Google Scholar 

  33. Silvertooth EJ, Doraiswamy PM, Clary GL, Babyak MA, Wilkerson N, Hellegars C, et al. Citalopram and quality of life in lung transplant recipients. Psychosomatics. [Clinical Trial Letter Randomized Controlled Trial]. 2004;45(3):271–2.

    Article  Google Scholar 

  34. He Y, Zheng Y, Xu C, Yang H, Wang Z, Zhou L, et al. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. Clin Respir J. [Randomized Controlled Trial]. 2016;10(3):318–25.

    Article  Google Scholar 

  35. Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. [Case Reports]. 1998;39(1):24–9.

    Article  CAS  Google Scholar 

  36. Wei YJ, Simoni-Wastila L, Albrecht JS, Huang TY, Moyo P, Khokhar B, et al. The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: a longitudinal cohort study. Int J Geriatr Psychiatry. 2018;33(2):e212–e20.

    Article  Google Scholar 

  37. Thompson WL, Smolin YL. Respiratory disorders. In: Ferrando S, Levenson J, Owen JA, editors. Clinical manual of psychopharmacology in the medically ill. 1st ed. Washingon, DC: American Psychiatric Publishing; 2010. p. 213–36.

    Google Scholar 

  38. Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: recognition and management. Cleve Clin J Med. 2018;85(2 Suppl 1):S11–S8.

    Article  Google Scholar 

  39. Sher Y. Psychiatric aspects of lung disease in critical care. Crit Care Clin. [Review]. 2017;33(3):601–17.

    Article  Google Scholar 

  40. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. [Meta-Analysis Research Support, Non-U.S. Gov’t Review]. 2002;57(11):939–44.

    Google Scholar 

  41. Colman R, Singer LG, Barua R, Downar J. Outcomes of lung transplant candidates referred for co-management by palliative care: a retrospective case series. Palliat Med. 2015;29(5):429–35.

    Article  Google Scholar 

  42. Tselebis A, Bratis D, Pachi A, Moussas G, Ilias I, Harikiopoulou M, et al. A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients. Multidiscip Respir Med. 2013;8(1):41.

    Article  Google Scholar 

  43. Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One. [Meta-Analysis Research Support, Non-U.S. Gov’t Review]. 2013;8(4):e60532.

    Google Scholar 

  44. Farver-Vestergaard I, O’Toole MS, O’Connor M, Lokke A, Bendstrup E, Basdeo SA, et al. Mindfulness-based cognitive therapy in COPD: a cluster randomised controlled trial. Eur Respir J. 2018;51(2)

    Article  Google Scholar 

  45. Smith SM, Sonego S, Ketcheson L, Larson JL. A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease. BMJ Open Respir Res. 2014;1(1):e000042.

    Article  Google Scholar 

  46. Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR. Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest. [Research Support, Non-U.S. Gov’t]. 2011;139(3):609–16.

    Article  Google Scholar 

  47. Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, et al. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology. 2012;17(3):525–32.

    Article  Google Scholar 

  48. Matsuda T, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, et al. Depression is significantly associated with the health status in patients with idiopathic pulmonary fibrosis. Intern Med. 2017;56(13):1637–44.

    Article  Google Scholar 

  49. Lee YJ, Choi SM, Cho YJ, Yoon HI, Lee JH, Lee CT, et al. Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis. PLoS One. 2017;12(9):e0184300.

    Article  Google Scholar 

  50. Bors M, Tomic R, Perlman DM, Kim HJ, Whelan TP. Cognitive function in idiopathic pulmonary fibrosis. Chron Respir Dis. [Research Support, Non-U.S. Gov’t]. 2015;12(4):365–72.

    Article  Google Scholar 

  51. Verma S, Cardenas-Garcia J, Mohapatra PR, Talwar A. Depression in pulmonary arterial hypertension and interstitial lung diseases. N Am J Med Sci. [Review]. 2014;6(6):240–9.

    Google Scholar 

  52. Quittner AL, Saez-Flores E, Barton JD. The psychological burden of cystic fibrosis. Curr Opin Pulm Med. [Review]. 2016;22(2):187–91.

    Article  Google Scholar 

  53. Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519–1531.

    Article  CAS  Google Scholar 

  54. Quittner AL, Goldbeck L, Abbott J, Duff A, Lambrecht P, Sole A, et al. Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries. Thorax. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2014;69(12):1090–7.

    Google Scholar 

  55. Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B, Hempstead SE, et al. International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax. [Consensus Development Conference Research Support, Non-U.S. Gov’t]. 2016;71(1):26–34.

    Google Scholar 

  56. Goldbeck L, Fidika A, Herle M, Quittner AL. Psychological interventions for individuals with cystic fibrosis and their families. Cochrane Database Syst Rev. [Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review]. 2014(6):CD003148.

    Google Scholar 

  57. Fidika A, Herle M, Lehmann C, Weiss C, Knaevelsrud C, Goldbeck L. A web-based psychological support program for caregivers of children with cystic fibrosis: a pilot study. Health Qual Life Outcomes. [Comparative Study Research Support, Non-U.S. Gov’t]. 2015;13:11.

    Google Scholar 

  58. Adams C, Icheva V, Deppisch C, Lauer J, Herrmann G, Graepler-Mainka U, et al. Long-term pulmonal therapy of cystic fibrosis-patients with amitriptyline. Cell Physiol Biochem. [Observational Study]. 2016;39(2):565–72.

    Article  CAS  Google Scholar 

  59. Chinuck RS, Fortnum H, Baldwin DR. Appetite stimulants in cystic fibrosis: a systematic review. J Hum Nutr Diet. [Research Support, Non-U.S. Gov’t Review]. 2007;20(6):526–37.

    Article  CAS  Google Scholar 

  60. Gillman PK. A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biol Psychiatry. [Review]. 2006;59(11):1046–51.

    Article  CAS  Google Scholar 

  61. Kopp BT, Hayes D, Jr., Ghera P, Patel A, Kirkby S, Kowatch RA, et al. Pilot trial of light therapy for depression in hospitalized patients with cystic fibrosis. J Affect Disord. [Clinical Trial]. 2016;189:164–8.

    Article  Google Scholar 

  62. Vandemheen KL, O’Connor A, Bell SC, Freitag A, Bye P, Jeanneret A, et al. Randomized trial of a decision aid for patients with cystic fibrosis considering lung transplantation. Am J Respir Crit Care Med. [Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 2009;180(8):761–8.

    Google Scholar 

  63. Flattery MP, Pinson JM, Savage L, Salyer J. Living with pulmonary artery hypertension: patients’ experiences. Heart Lung. 2005;34(2):99–107.

    Article  Google Scholar 

  64. Vanhoof JMM, Delcroix M, Vandevelde E, Denhaerynck K, Wuyts W, Belge C, et al. Emotional symptoms and quality of life in patients with pulmonary arterial hypertension. J Heart Lung Transplant. 2014;33(8):800–8.

    Article  Google Scholar 

  65. Lowe B, Grafe K, Ufer C, Kroenke K, Grunig E, Herzog W, et al. Anxiety and depression in patients with pulmonary hypertension. Psychiatr Med. [Comparative Study Research Support, Non-U.S. Gov’t]. 2004;66(6):831–6.

    Google Scholar 

  66. Harzheim D, Klose H, Pinado FP, Ehlken N, Nagel C, Fischer C, et al. Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Res. [Comparative Study]. 2013;14:104.

    Article  Google Scholar 

  67. Von Visger TT, Kuntz KK, Phillips GS, Yildiz VO, Sood N. Quality of life and psychological symptoms in patients with pulmonary hypertension. Heart Lung. 2018;47(2):115–21.

    Google Scholar 

  68. White J, Hopkins RO, Glissmeyer EW, Kitterman N, Elliott CG. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res. [Comparative Study Research Support, Non-U.S. Gov’t]. 2006;7:55.

    Google Scholar 

  69. MacLean MR, Dempsie Y. Serotonin and pulmonary hypertension – from bench to bedside? Curr Opin Pharmacol. [Research Support, Non-U.S. Gov’t Review]. 2009;9(3):281–6.

    Google Scholar 

  70. Sadoughi A, Roberts KE, Preston IR, Lai GP, McCollister DH, Farber HW, et al. Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension. Chest. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. 2013;144(2):531–41.

    Google Scholar 

  71. Kawut SM, Horn EM, Berekashvili KK, Lederer DJ, Widlitz AC, Rosenzweig EB, et al. Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulm Pharmacol Ther. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. 2006;19(5):370–4.

    Google Scholar 

  72. Fox BD, Azoulay L, Dell’Aniello S, Langleben D, Lapi F, Benisty J, et al. The use of antidepressants and the risk of idiopathic pulmonary arterial hypertension. Can J Cardiol. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2014;30(12):1633–9.

    Google Scholar 

  73. Li Y, Wang R, Tang J, Chen C, Tan L, Wu Z, et al. Progressive muscle relaxation improves anxiety and depression of pulmonary arterial hypertension patients. Evid Based Complement Alternat Med. 2015;2015:792895.

    PubMed  PubMed Central  Google Scholar 

  74. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. [Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 2006;114(14):1482–9.

    Google Scholar 

  75. Soyseth TS, Lund MB, Bjortuft O, Heldal A, Soyseth V, Dew MA, et al. Psychiatric disorders and psychological distress in patients undergoing evaluation for lung transplantation: a national cohort study. Gen Hosp Psychiatry. 2016;42:67–73.

    Article  Google Scholar 

  76. Smith PJ, Snyder LD, Palmer SM, Hoffman BM, Stonerock GL, Ingle KK, Saulino CK, Blumenthal JA. Depression, social support, and clinical outcomes following lung transplantation: a single-center cohort study. Transpl Intern. 2018;31(5):495–502.

    Article  CAS  Google Scholar 

  77. Farquhar JM, Smith PJ, Snyder L, Gray AL, Reynolds JM, Blumenthal JA. Patterns and predictors of pain following lung transplantation. Gen Hosp Psychiatry. 2018;50:125–30.

    Article  Google Scholar 

  78. Evon DM, Burker EJ, Sedway JA, Cicale R, Davis K, Egan T. Tobacco and alcohol use in lung transplant candidates and recipients. Clin Transpl. [Research Support, Non-U.S. Gov’t]. 2005;19(2):207–14.

    Article  Google Scholar 

  79. Zmeskal M, Kralikova E, Kurcova I, Pafko P, Lischke R, Fila L, et al. Continued smoking in lung transplant patients: a cross sectional survey. Zdravstveno varstvo. 2016;55(1):29–35.

    PubMed  Google Scholar 

  80. Vos R, De Vusser K, Schaevers V, Schoonis A, Lemaigre V, Dobbels F, et al. Smoking resumption after lung transplantation: a sobering truth. Eur Respir J. [Letter Research Support, Non-U.S. Gov’t]. 2010;35(6):1411–3.

    Article  CAS  Google Scholar 

  81. Ruttens D, Verleden SE, Goeminne PC, Poels K, Vandermeulen E, Godderis L, et al. Smoking resumption after lung transplantation: standardised screening and importance for long-term outcome. Eur Respir J. [Letter Research Support, Non-U.S. Gov’t]. 2014;43(1):300–3.

    Article  Google Scholar 

  82. Lowery EM, Yong M, Cohen A, Joyce C, Kovacs EJ. Recent alcohol use prolongs hospital length of stay following lung transplant. Clin Transpl. 2018;5:e13250.

    Article  Google Scholar 

  83. Smith PJ, Rivelli S, Waters A, Reynolds J, Hoyle A, Flowers M, et al. Neurocognitive changes after lung transplantation. Ann Am Thorac Soc. 2014;11(10):1520–7.

    Article  Google Scholar 

  84. Smith PJ, Rivelli SK, Waters AM, Hoyle A, Durheim MT, Reynolds JM, et al. Delirium affects length of hospital stay after lung transplantation. J Crit Care. 2015;30(1):126–9.

    Article  CAS  Google Scholar 

  85. Kennedy CC, Zubair A, Clark MM, Jowsey-Gregoire S. Childhood abuse is associated with worse survival following lung transplantation. Prog Transplant. [Research Support, Non-U.S. Gov’t]. 2016;26(2):178–82.

    Article  Google Scholar 

  86. DiGangi JA, Gomez D, Mendoza L, Jason LA, Keys CB, Koenen KC. Pretrauma risk factors for posttraumatic stress disorder: a systematic review of the literature. Clin Psychol Rev. [Review]. 2013;33(6):728–44.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA

    Yelizaveta Sher

Authors
  1. Yelizaveta Sher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yelizaveta Sher .

Editor information

Editors and Affiliations

  1. Stanford University School of Medicine, Stanford, CA, USA

    Yelizaveta Sher

  2. Stanford University School of Medicine, Stanford, CA, USA

    José R. Maldonado

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sher, Y. (2019). Mental Health in Chronic and End-Stage Lung Disease. In: Sher, Y., Maldonado, J. (eds) Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-94914-7_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94914-7_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94913-0

  • Online ISBN: 978-3-319-94914-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation